Paul R. Lichter
About
In The Last Decade
Paul R. Lichter
97 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Ophthalmology 5.2k
- Radiology, Nuclear Medicine and Imaging 3.1k
- Molecular Biology 926
- Pathology and Forensic Medicine 657
- Public Health, Environmental and Occupational Health 626
Countries citing papers authored by Paul R. Lichter
This map shows the geographic impact of Paul R. Lichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Lichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Lichter more than expected).
Fields of papers citing papers by Paul R. Lichter
This network shows the impact of papers produced by Paul R. Lichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Lichter. The network helps show where Paul R. Lichter may publish in the future.
Co-authorship network of co-authors of Paul R. Lichter
This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Lichter. A scholar is included among the top collaborators of Paul R. Lichter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Lichter. Paul R. Lichter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Stepped Medication Use, Associated Symptoms, and Treatment Failure among Participants in the Medication Arm of the Collaborative Initial Glaucoma Treatment Study | 2 |
| 2 | 50 | |
| 3 | 91 | |
| 4 | Argon Laser Trabeculoplasty (ALT) after Initial Medicine or Surgery in the Collaborative Initial Glaucoma Treatment Study (CIGTS): Predictive Factors and Need for Further Intervention | 1 |
| 5 | 326 | |
| 6 | Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds. | 12 |
| 7 | 109 | |
| 8 | 54 | |
| 9 | Baseline Factors Associated With IOP Mean and Variability During Long–Term Treatment for Newly–Diagnosed Open–Angle Glaucoma | 1 |
| 10 | Depression, Mood Indicators, and Self–Reported Visual Function at Baseline in the Collaborative Initial Glaucoma Treatment Study | 1 |
| 11 | 7 | |
| 12 | The Impact of Cataract Surgery on Visual Acuity, Visual Field, and Quality of Life for Patients in the CIGTS | 1 |
| 13 | 173 | |
| 14 | 42 | |
| 15 | 158 | |
| 16 | A trabecular meshwork glucocorticoid response (TIGR) gene mutation affects translocational processing. | 32 |
| 17 | GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. | 89 |
| 18 | 11 | |
| 19 | 132 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.